Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster


Applied Clinical Trials

Symbio LLC has announced the signing of a five-year contract with OmniComm Systems, Inc., to use their TrialMaster version 5 to develop and manage clinical study databases.  

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
Related Content
© 2024 MJH Life Sciences

All rights reserved.